CFRA Downgrades Lululemon Athletica: From Strong Buy to Hold Amidst Inventory Woes and Revised Outlook

CFRA Research, a well-regarded analysis firm, has shifted its stance on Lululemon Athletica (NASDAQ: LULU), moving its rating from Strong Buy to Hold. This revision comes alongside a notable cut in the price target, which now stands at $280, down from a previous $400. The adjustment is heavily influenced by the firm’s assessment of Lululemon's projected earnings per share (EPS) for its fiscal year 2025, which wraps up in January, pegged at a 20.0x multiple. Remarkably, this figure is significantly lower than Lululemon's one-year average forward price-to-earnings (P/E) multiple of 26.9x.

The primary catalyst for this downgrade is CFRA's growing concerns regarding inventory challenges that Lululemon is currently grappling with as the essential holiday shopping period approaches. These inventory hurdles have the potential to impede sales performance in both the third and fourth quarters. The analysts have observed a near 20% rebound from the shares' low following the company's second-quarter earnings report, and they now anticipate that a phase of consolidation is on the horizon for the stock. "We believe shares are due for consolidation," they noted.

Despite incorporating this cautious outlook, CFRA retains a positive long-term view on Lululemon. The brand's strong appeal across diverse demographics and significant growth prospects in international markets, particularly within Mainland China, bolster this optimistic perspective. However, analysts caution that the company might face difficulties in launching the right products in the short term.

Furthermore, the company has recently revised its expectations downward. Lululemon reported its first revenue miss in over two years in late August, following a problematic product rollout and slowing growth in its domestic market. The new revenue projections suggest annual net sales will fall between $10.38 billion and $10.48 billion, adjusted from an earlier outlook of $10.7 billion to $10.8 billion. Moreover, the anticipated EPS has been revised to a range of $13.95 to $14.15, a reduction from the previous estimate of $14.27 to $14.47.